title: Does MDR-1 G2677T/A polymorphism really associate with ovarian cancer response to paclitaxel chemotherapy?
authors.forename: Agnieszka H
authors.initials: AH
authors.lastname: Ludwig
authors.forename: Jolanta
authors.initials: J
authors.lastname: Kupryjañczyk
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000235:genetics*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D005260:Female; D014644:Genetic Variation; D006801:Humans; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology; D017239:Paclitaxel / Q000627:therapeutic use*; D011044:Poland; D020641:Polymorphism, Single Nucleotide
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D017239:Paclitaxel